FDA Approved: PARICALCITOL — Supplemental Application (Eugia US LLC)

View source ↗

Summary

The FDA approved a supplemental application for paricalcitol from Eugia US LLC. Paricalcitol is a vitamin D analog used to treat secondary hyperparathyroidism i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

SUPPL AP for PARICALCITOL (PARICALCITOL)